Results for tag: "Korlym"

Korlym is a prescription drug used to treat hyperglycemia associated with endogenous Cushing's Syndrome, a rare endocrine and metabolic disorder. It works by blocking the effects of cortisol, a hormone produced by the adrenal glands. Korlym is the only FDA-approved medication for this condition. It is taken orally, usually once a day, and is available in tablet form. Side effects may include nausea, vomiting, diarrhea, and dizziness. Korlym is marketed by Corcept Therapeutics, a biopharmaceutical company based in California. Other companies in the market include Novo Nordisk, Sanofi, and Pfizer. Show Less Read more